Quantitative Study of Breast Cancer Progression: Different Pathways for Various In Situ Cancers
β Scribed by Mariuzzi, L.; Mombello, A.; Granchelli, G.; Rucco, V.; Tarocco, E.; Frank, D.; Davis, J.; Thompson, D.; Bartels, H.; Mariuzzi, G. M.
- Book ID
- 109889742
- Publisher
- Nature Publishing Group
- Year
- 2002
- Tongue
- English
- Weight
- 411 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0893-3952
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract APβ2Ξ±, interleukinβ4 (ILβ4), Eβcadherin, fibulin 1D, p16^INK4Ξ±^, PTEN, RKIP, and S100A4 are determinants (suppressors, except for S100A4) of cancer cell invasiveness and other traits of cancer progression, which are located upstream of matrix metalloproteinases (MMPs) in cell signaling
We observed previously that each of seven cancer progression inhibitors suppresses the mRNA expression of some matrix metalloproteinases (MMPs), but stimulates that of others, in breast cancer cells. In the present study we tested the effect of overexpressing other cancer modulators on MMP expressio
## Abstract Previously we detected new signaling pathways, some downregulatory and others upregulatory, from seven known suppressors of cancer progression to the expression of eight cancerβpromoting matrix metalloproteinases (MMPs) in breast cancer cells. The goals of the present study were to test
In J Cell Physiol 224:549-558, a production error deleted all of the original gray discs from Table 1 and its legend. The correct, originally submitted version of Table 1 is shown below. In conjunction with this erratum, the online files of the article have been amended accordingly and the updated a